๐
Temybric Ellipta
fluticasone furoate;umeclidinium;vilanterol
Pulmonary Disease, Chronic Obstructive
โน๏ธ Lapsed
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Temybric Ellipta is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting ?2-agonist or a combination of a long-acting ?2-agonist and a long-acting muscarinic antagonist (for effects on symptom control and prevention of exacerbations see section 5.1).
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/temybric-ellipta